Evidence map›Paper›PMID 22419927›Full record

ArticleArchives of medical science : AMS2010

Changes in attainment of lipid goals by general practitioners and specialists in patients at high cardiovascular risk in Hungary during 2004-2008.

Laszlo Mark, György Paragh, Istvan Karadi, Istvan Reiber, Gyula Pados

Abstract read
In one paragraph

Article in Archives of medical science : AMS, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Persistence with statin therapy in Hungary.Archives of medical science : AMS · 2013
    Article
  2. Article
  3. Article
  4. Lipids, blood pressure, kidney - what was new in 2011?Archives of medical science : AMS · 2011
    Article
  5. The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice.Medical science monitor : international medical journal of experimental and clinical research · 2011
    Article
  6. Article
  7. Are we getting to lipid targets in real life?Archives of medical science : AMS · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laszlo Mark2 Department of Internal Medicine - Cardiology, Pandy Kalman Bekes County Hospital, Gyula, Hungary.
György Paragh
Istvan Karadi
Istvan Reiber
Gyula Pados

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLipid-lowering therapy should achieve target levels. We assessed the change of the achievement of targets and the mean low-density lipoprotein cholesterol (LDL-C) levels in high-risk Hungarian patients. MATERIAL AND

methodsSix studies performed with patients of general practitioners (GPs) and specialists between 2004 and 2008 were evaluated: 9,508 patients from GPs and 2809 from specialist practices (total 12,317).

resultsDuring this 4-year period the LDL-C level decreased by 0.73 mmol/l and the LDL-C goal achievement rate increased from 14 to 32% in patients treated by GPs. LDL-C showed a decrease of 0.48 mmol/l and the goal achievement rate changed from 20 to 43% in patients treated by specialists. In the majority of the patients not achieving the LDL-C goal (57% for specialists and 89% for GPs) there was no modification in the current therapy. In addition to emphasizing the priority of LDL-C lowering, we should also strive for residual risk reduction, which means raising high-density lipoprotein cholesterol (HDL-C) and lowering triglyceride levels. There was no significant improvement in HDL-C or triglyceride levels during the examined period.

conclusionMore attention needs to be paid to changing treatment of patients to achieve target levels.

Indexed as

hypercholesterolaemiaLDL cholesterolpreventionrisk factorsstatins

Identifiers

PMID22419927
PMCPMC3298337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.